Abiopharma

News list

(90% Positive) Sanofi (SNY) Announces Regulatory Update (Form 6-K)

Full text

News bot Oct. 18, 2025, 5:40 p.m.
🌍 Sanofi (SNY) - Form 6-K Filing

Filing Date: 2022-06-28

Accepted: 2022-06-28 15:59:59

Event Type: Regulatory Update

Event Details:

Sanofi-GSK first to report a successful efficacy study against Omicron. Primary vaccination with Beta-containing vaccine candidate delivers 64.7% efficacy against symptomatic infection in adults, and 75.1% efficacy in participants previously infected with COVID-19.
💼 Business Developments:
- ✅ Partnership/Collaboration
- ❌ Acquisition Activity: Not reported
- ❌ Licensing Agreement: Not reported
- ✅ Regulatory Milestone
- ❌ Leadership Updates: Not reported
📞 Contact Information:
- Email: sandrine.guendoul@sanofi.com